Centene Corporation (CNC)
75.44 USD -1.99 (-2.57%) Volume: 4.2M
Centene Corporation’s stock price currently stands at 75.44 USD, experiencing a dip of -2.57% this trading session. Despite the slight drop, the stock maintains a positive Year-to-Date (YTD) growth of +1.66%, backed by a robust trading volume of 4.2M. A firm to watch for investors seeking steady growth.
Latest developments on Centene Corporation
Today, Centene Corp (NYSE:CNC) experienced stock price movements following key events in the market. Atria Investments Inc was seen increasing its stock holdings in the company, while B. Riley Wealth Advisors Inc opted to sell Centene Co. shares. Additionally, analysts raised the price target for Centene (NYSE:CNC) to $87.00, indicating a positive outlook for the company’s performance. These developments likely contributed to the fluctuations in Centene Corp‘s stock price today.
Centene Corporation on Smartkarma
Analyst coverage of Centene Corp on Smartkarma has been positive, with reports from Baptista Research highlighting the company’s strong financial performance in the first quarter of the year. In their research reports, Baptista Research noted that Centene Corporation exceeded expected adjusted earnings per share (EPS) at $2.26, leading to an upward revision in their full-year 2024 forecast to over $6.80 per share. Despite showcasing operational efficiency and progress, the reports also acknowledge ongoing challenges that the company faces.
Furthermore, Baptista Research‘s analysis on Centene Corp emphasizes the company’s strategic maneuvers and positive developments in the first quarter of 2024. The reports mention that Centene Corporation achieved a higher-than-expected adjusted EPS of $2.26, prompting an upward revision in its full-year 2024 EPS guidance to over $6.80. These findings suggest a strong start to the year for Centene Corp, attributed to significant operational improvements and strategic realignments aimed at sustaining and enhancing its business operations.
A look at Centene Corporation Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 1 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Centene Corporation, a multi-line managed care organization specializing in Medicaid programs, shows a promising long-term outlook based on its Smartkarma Smart Scores. With high scores in Growth, Resilience, and Momentum, the company is positioned for continued expansion and success in the market. This indicates that Centene Corp is well-equipped to capitalize on growth opportunities, navigate challenges effectively, and maintain a strong market position over the long term.
Although Centene Corp scores low in the Dividend category, its strong performance in other key areas bodes well for its future prospects. The company’s focus on providing Medicaid and Medicaid-related programs, along with specialty services like behavioral health, nurse triage, and treatment compliance, positions it as a key player in the healthcare industry. Investors and stakeholders can look forward to a company that is primed for growth and resilience in the face of market fluctuations.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
